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Abstract
Background: Indeterminate results are a recognised limitation of interferon-c release assays (IGRA) in the diagnosis of latent
tuberculosis (TB) infection (LTBI) and TB disease, especially in children. We investigated whether age and common co-
morbidities were associated with IGRA performance in an unselected cohort of resettled refugees.
Methods: A retrospective cross-sectional study of refugees presenting for their post-resettlement health assessment during
2006 and 2007. Refugees were investigated for prevalent infectious diseases, including TB, and for common nutritional
deficiencies and haematological abnormalities as part of standard clinical screening protocols. Tuberculosis screening was
performed by IGRA; QuantiFERON-TB Gold in 2006 and QuantiFERON-TBGold In-Tube in 2007.
Results: Complete data were available on 1130 refugees, of whom 573 (51%) were children less than 17 years and 1041
(92%) were from sub-Saharan Africa. All individuals were HIV negative. A definitive IGRA result was obtained in 1004 (89%)
refugees, 264 (26%) of which were positive; 256 (97%) had LTBI and 8 (3%) had TB disease. An indeterminate IGRA result was
obtained in 126 (11%) refugees (all failed positive mitogen control). In multivariate analysis, younger age (linear OR =0.93
[95% CI 0.91–0.95], P,0.001), iron deficiency anaemia (2.69 [1.51–4.80], P=0.001), malaria infection (3.04 [1.51–6.09],
P=0.002), and helminth infection (2.26 [1.48–3.46], P,0.001), but not vitamin D deficiency or insufficiency, were associated
with an indeterminate IGRA result.
Conclusions: Younger age and a number of common co-morbidities are significantly and independently associated with
indeterminate IGRA results in resettled predominantly African refugees.
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Introduction
Mycobacterium tuberculosis (MTB) infects over one third of the
global population and tuberculosis (TB) disease results in
approximately 1.3 million deaths annually, largely in high in-
cidence, resource-poor countries. [1] With increasing migration
from high to low incidence regions, the majority of TB
notifications in resource-rich countries such as Australia [2] and
the UK [3] are in those born overseas. Active TB disease results
either from reactivation of latent TB infection (LTBI), or from
uncontrolled primary infection, particularly in younger children,
who usually acquire infection from an infectious adult. [4] The
greatest risk of progression from TB infection to disease is in the
post-migration period. Identification and treatment of those with
asymptomatic LTBI is therefore an important component of the
initial health assessment of refugees and others from high
incidence regions. Coordinated TB screening of high risk
individuals is integral to national TB control policies in resource-
rich countries, [5,6] and reduces the overall transmission rate of
TB. [7,8,9].
Given the delay and difficulties in reaching a microbiological
diagnosis of TB disease, especially in children, and the lack of
positive microbiology in LTBI, the diagnosis of TB infection is
mostly reliant on the demonstration of immunological memory to
mycobacterial antigens. The tuberculin skin test (TST) remains
widely used for this purpose, despite well-documented limitations,
especially in relation to specificity. [10] Interferon-c release assays
(IGRA), which quantify the interferon (IFN)-c response of whole
blood (QuantiFERONH-TB Gold, QFT and QuantiFERONH-TB Gold
In-Tube, QFT-IT, Cellestis, Australia) or isolated mononuclear
cells (T-Spot.TB, Immunotech, UK) to largely MTB-specific
antigens, are increasingly used in resource-rich settings. [11] These
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screening tools for LTBI remains poorly defined. Indeterminate
results, which are reported in up to 35% of QFT [12,13] and 15%
of QFT-IT assays [14] are a significant potential limitation to their
utility, particularly in young and/or immunocompromised
patients. [12,15,16].
Immune responses to TB are influenced by a variety of factors,
including younger age, vitamin D insufficiency or deficiency, and
concurrent infections, particularly malaria, helminth and viral
infections. [17,18,19] The effect of iron deficiency on TB
responses are ill-defined, but iron deficiency impairs cellular
immune responses and increases susceptibility to infection more
generally. [20] There are limited data on whether these factors
affect the performance of IGRA.
We investigated the effect of these co-morbidities on the
performance of QFT and QFT-IT as a screening tool for TB
infection in a large cohort of recently resettled unselected
paediatric and adult refugees in Australia.
Methods
Study Population and Design
Ethical approval was obtained from the Princess Margaret
Hospital for Children Ethics Committee, Perth, Western Australia,
Australia (Governance Evidence Knowledge Outcomes approval). This was
a retrospective cross-sectional study of unselected consecutive
newly arrived refugees, who had an initial health assessment at
a designated refugee health assessment centre (Perth, Western
Australia, Australia) between 1st January 2006 and 31st Decem-
ber 2007. The study population included 265 children (of a total of
573 refugee children included, 46.2%) who were previously
enrolled in a reported comparative study of QFT-IT, T-SPOT.TB
and TST in Asian and African refugee children, for which
experimental blood sampling was only performed once routine
screening investigations had been completed. [14] The current
study was a larger and more detailed assessment of IGRA
performance (both QFT and QFT-IT), with additional paediatric
subjects and the inclusion of adults, as well as analysis of additional
common co-morbid conditions.
The initial refugee health assessment is performed over two
visits, with routine information collected on country of birth and of
refuge, seasonality of health assessment, and body mass index. [21]
It was not possible to obtain an accurate TB contact history, as
many refugees previously lived in over-crowded refugee camps,
[22] and the usual parameters for defining ‘household contact’
were difficult to ascertain.
Laboratory investigations included an immunochromatographic
assay for Plasmodium falciparum (Binax NOWH, Portland, USA),
single thick and thin blood films for malaria, serology for
schistosomiasis (enzyme immunoassay, EIA or indirect haemag-
glutination assay, IHA) and for strongyloidiasis (EIA), [21]
automated full blood count and leucocyte differential, iron stores
(iron, transferrin, transferrin saturation and ferritin), total calcium,
phosphate, alkaline phosphatase and 25-hydroxyvitamin D, all
performed by standard laboratory assays. Analysis of stool
specimens for faecal parasites is not part of the routine health
assessment in Western Australia and approximately 80% of
refugees received empiric anti-helminth treatment shortly before
migration.
Interferon-c Release Assays
All subjects had an IGRA (QFT during 2006 and QFT-IT from
2007 onwards). The Western Australian TB Control Program
replaced TST with IGRA as the preferred TB screening method,
partly because of logistical difficulties in accessing recently resettled
and often mobile refugee patients 48–72 h post-TST. [14] A single
IGRA was performed on each patient at the initial health
screening in accordance with the manufacturer’s instructions. Both
QFT and QFT-IT use phytohaemagluttinin (PHA) as the positive
mitogen control and have an antigen-free negative (nil) control. In
the QFT, responses to MTB-specific antigens CFP-10 and ESAT-
6 are assayed in two separate tubes, whereas the QFT-IT uses
a single tube containing the antigens CFP-10, ESAT-6 and TB7.7.
Interpretation of the IGRA result was according to the
manufacturer’s guidelines. A positive IGRA result was defined as
an IFN-c response to one or more MTB-specific antigens above
the recommended cut-off, irrespective of the IFN-c response to the
mitogen control. A negative IGRA result was an IFN-c response
below cut-off for all MTB-specific proteins, with a response to the
mitogen control above cut-off. An indeterminate result was
defined as either an IFN-c response below the cut-off for both
MTB-specific proteins and the mitogen control, or an IFN-c
response above the cut-off in the nil control.
Haematological analyses
Anaemia was defined as a concentration of haemoglobin less
than age and gender-adjusted values used in the Western
Australian population (PathWest Laboratories, Perth, Western
Australia). Iron deficiency was defined by at least two abnormal
iron parameters (iron, ferritin, transferrin and transferrin satura-
tion, corrected for age and gender norms). [23] Iron deficiency
anaemia was defined as coexisting iron deficiency and anaemia.
The serum 25-hydroxyvitamin D levels were classified according
to international standards of deficient (,27.5 nmol/L), insufficient
(27.5–78 nmol/L) and sufficient (.78 nmol/L). [24].
Diagnosis of Infectious Diseases
Helminth infection was identified by a positive serology for
schistosomiasis (EIA.1.2 and/or IHA.16), and/or positive
serology for strongyloides (EIA.0.45), and/or a peripheral
eosinophil count of $0.7610
9/L. Equivocal serology for either
schistosomiasis or strongyloides was not considered indicative of
infection if the eosinophil count was below the diagnostic cut-off.
Malaria infection was diagnosed by either a positive blood film
and/or a positive immunochromatographic test for P. falciparum.
Statistical Analysis
Analyses were performed using data from patients with no
missing clinical, demographic or laboratory data. Univariate
logistic regression models were used to obtain unadjusted odds
ratios for all characteristics potentially associated with a positive
(versus negative) or an indeterminate (versus definite positive or
negative) IGRA result. Age was centred at the median to allow
inclusion of a quadratic effect for this characteristic. The models
for malaria, helminth infection, iron deficiency and iron deficiency
anaemia were additionally assessed using characteristic*age in-
teraction effects to look for possible modification of the effect of
each characteristic by age. Multivariate logistic regression models
were used to identify characteristics that were independently
associated with a IGRA positive result and, separately, to identify
factors independently associated with an indeterminate result. All
characteristics were provisionally included in the multivariate
models and backward elimination was used to remove character-
istics sequentially. At each step, the characteristic with the largest
multivariate P-value was removed. The final models included only
those characteristics with multivariate P,0.05. Multiple imputa-
tion was used to ascertain whether exclusion of individuals from
analyses, due to incomplete data, may have introduced bias in the
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imputed and analysed with multivariate logistic regression with the
50 sets of regression results combined using Rubin’s rules. [25] All
analyses were performed using Stata version 10.1 (Stata Corpo-
ration, College Station, TX).
Results
Patient Characteristics
A total of 1760 refugees were assessed during the study period
and complete data were available on 1130 (64%). There were 573
(51%) children (,17 years) and 557 (49%) adults. Just under half
(49%) were male. The majority of refugees (1041, 92%) were from
sub-Saharan Africa, with the remainder from Asia, predominantly
Myanmar (Table 1).
Of the 1130 refugees, 438 (39%) had a QFT and 692 (61%) had
a QFT-IT. A definitive (non-indeterminate) IGRA result was
obtained in 1004 (of 1130, 89%), of which 264 (26%) were
positive. Of those with a positive IGRA, eight (3%) had TB
disease, which was diagnosed by clinical, radiological and/or
microbiological parameters by experienced physicians. Of the 126
(11%) refugees with an indeterminate IGRA result, all were the
result of a failed positive mitogen control. Malaria infection was
present in 44 (4%) individuals and a helminth infection in 444
(39%), of which the majority were schistosomiasis. Iron deficiency
was present in 166 (15%) and iron deficiency anaemia in
approximately half of these (7%). Over 85% of the cohort was
either vitamin D insufficient (79%) or deficient (7%) (Table 2).
Characteristics Associated with a Positive IGRA Result
In the univariate analysis, older age (linear odds ratio 1.10, 95%
confidence interval (CI) 1.08–1.12, P,0.001) and a health
assessment performed in summer (P=0.022, compared to other
seasons) were independently associated with positive IGRA.
Vitamin D status was not associated with a positive IGRA result
on univariate analysis and was therefore not carried forward into
the multivariate model (Table 3). There was a strong positive
linear association between age and the odds of a positive IGRA
result until approximately 30 years of age, beyond which the
association declined (Figure 1). The modest reversal in this trend
from approximately 45 years of age onwards was not significant
(cubic effect coefficient for age P=0.64).
Characteristics Associated with an Indeterminate IGRA
Result
Younger age, helminth infection, malaria infection, and iron
deficient anaemia were significantly and independently associated
with an indeterminate IGRA result (Table 4). The odds of an
indeterminate IGRA result decreased linearly with increasing age
(linear odds ratio (OR) 0.93, 95% CI 0.91–0.95, P,0.001). At
approximately 15 years of age this association gradually declined
with no evidence of an association between age and indeterminate
IGRA beyond 25–35 years (Figure 2). Helminth infection (OR
2.26, 95% CI 1.48–3.46, P,0.001), malaria infection (OR 3.04,
95% CI 1.51–6.09, P=0.002), and iron deficient anaemia (OR
2.69, 95% CI 1.51–4.80, P=0.001) all significantly increased the
odds of an indeterminate IGRA result. Vitamin D insufficiency or
deficiency had no effect on the likelihood of an indeterminate
IGRA result. Multivariate logistic regression results derived from
multiple imputation for characteristics associated with a positive
IGRA or indeterminate IGRA differed little from results derived
from refugees with complete data (data not shown).
The associations between an indeterminate IGRA and malaria
infection, helminth infection, iron deficiency and iron deficiency
anaemia were not modified by age; the interaction effects added to
the relevant univariate models were all non-significant (malaria*-
age P=0.153; helminth infection*age P=0.497; iron deficiency*-
age P=0.237; and iron deficient anaemia*age P=0.460).
Discussion
In this large retrospective study of recently resettled pre-
dominantly African child and adult refugees, more than a quarter
had a positive IGRA, the majority due to LTBI. This is
comparable to data reported from paediatric [14,26,27] and adult
refugees [28] resettled in Australia and other resource-rich
countries. One in eight individuals had an indeterminate IGRA
result, all due to failure of the positive mitogen control. An
indeterminate result complicates management and increases costs,
as further TB diagnostic testing (by TST and/or an alternative
IGRA) and other investigations are often necessary. Younger age,
concurrent malaria or helminth infection, iron deficiency and iron
deficiency anaemia were significantly and independently associat-
ed with an indeterminate IGRA result. In a previous study that
included a sub-set of children from the current cohort, we found
that helminth infection, and either malaria or viral hepatitis
infection, increased the likelihood of an indeterminate QFT-IT.
[14] The current study confirms and extends these findings. The
Table 1. Demographic characteristics of study population
(n=1130).
Characteristic Estimate*
Age (years) 19.8613.4
Gender: male (%) 552 (48.8%)
Country of Birth (%)
Africa 1041 (92.1%)
Sudan 318 (28.1%)
Congo 140 (12.4%)
Liberia 113 (10.0%)
Burundi 78 (6.9%)
Tanzania 58 (5.1%)
Sierra Leonne 57 (5.0%)
Africa: other** 277 (24.5%)
Asia 88 (7.8%)
Burma 68 (6.0%)
Asia: Other
+ 20 (1.8%)
Other
++ 1 (0.1%)
Seasonality of MHU visit (%)
Summer 156 (13.8%)
Autumn 239 (21.1%)
Winter 355 (31.4%)
Spring 380 (33.6%)
Body mass index (kg/m
2) 20.364.7
MMR vaccine received (%) 830 (73.4%)
*Estimate values represent mean 6 standard deviation or median (interquartile
range) or frequency (percent) of study population.
**Other represents 17 countries of birth in Africa with ,4% of study
population.
+Other represents 2 countries of birth in Asia with ,4% of study population.
++Other represents 1 country of birth outside of Asia or Africa with ,4% of
study population.
doi:10.1371/journal.pone.0038556.t001
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for age-modifying effects, none of which were statistically
significant, indicates that these are not age-specific associations.
The aetiology of the failed positive mitogen control responsible
for the indeterminate IGRA results is likely to be multi-factorial. T
cell production of IFN-c, a prototypical T-helper 1 (Th1) cytokine
is relatively deficient in younger children, [29] partly due to
increased methylation of the IFN-c promoter. [30] Helminth
infection induces a Th2 immune phenotype, with concomitant
reduced Th1 response and increased regulatory T-cells, which
reduces overall IFN-c production. [31] In a small study of Indian
adult patients with LTBI, concurrent filarial infection, which is
known to suppress Th1 and enhance Th2 responses, was
associated with down regulation of IFN-c and enhanced in-
terleukin (IL)-4 responses to mycobacterial antigens in vitro. [32]
Although screening for filarial infection is not part of standard care
in refugees resettled in Australia, the immunological mechanisms
may be similar to those in helminth infection and both filarial and
helminth infections suppress responses to BCG vaccination. [33].
Malaria was also associated with increased risk of an in-
determinate IGRA result. Despite the considerable epidemiolog-
ical overlap between these two major causes of global mortality,
there are few data on the interaction between malaria and
immune responses to MTB. In the resettled refugee population,
many malarial infections are chronic, with low level parasitaemia
and minimal symptoms. [34,35] Both acute and chronic asymp-
tomatic malaria infection are broadly immunosuppressive, in-
creasing susceptibility to infection with other pathogens such as
salmonella and reducing responses to polysaccharide vaccines.
[36] Similar mechanisms may contribute to reduced mitogen
responses in IGRA.
The lack of an association between reduced vitamin D levels
and IGRA performance was an unexpected finding. Low levels of
vitamin D are present in the majority of resettled refugees in
Australia. [22] Vitamin D is a key modulator of the complex
immune responses to TB infection [37] and was used as an anti-
TB agent in the pre-antibiotic era. [38] Reduced vitamin D levels
are associated with increased risk of progression from LTBI to TB
disease in Indian adults recently resettled in the UK. [39] In vitro
responses to mycobacterial antigens are associated with functional
polymorphisms of the vitamin D binding protein, an effect that is
only observed in those who were also vitamin D deficient. [40]
Vitamin D supplementation of in vitro human T cells selectively
reduces mitogen responses and IL-2 production, possibly due to
the lack of accessory cells. [41] A single dose of vitamin D
supplementation given to adults with LTBI increased their IFN-c
responses to mycobacterial antigens. [42] It is unclear why low
levels of vitamin D did not affect the IGRA responses in the
current study.
The association between a positive IGRA result and summer
months was not mediated by differences in vitamin D levels.
Refugees are often resettled in large groups from specific countries
of refuge, such as a single refugee camp. Thus the seasonal
association may reflect increased local prevalence of TB infection
in a specific group of refugees who were resettled en masse in late
spring in early summer (and therefore had an IGRA performed
during the summer months), although this is difficult to sub-
stantiate.
The strengths of the current study include the size of the
unselected cohort, which included both children and adults and
which was representative of the resettling refugee population in
Australia during the study period. All participants were in-
vestigated using standardised and extensive investigations.
Limitations include the fact that the majority of the cohort was
Table 2. Clinical characteristics of study population
(n=1130).
Characteristic Estimate*
IGRA result**(%)
Positive 264 (23.4% of all IGRA results)
Positive: $17 years 207 (78.4% of positive IGRA results)
Positive: ,17 years 57 (21.6% of positive IGRA results)
Negative 740 (65.5% of all IGRA results)
Negative: $17 years 317 (42.8% of negative IGRA results)
Negative: ,17 years 423 (57.2% of negative IGRA results)
Indeterminate 126 (11.1% of all IGRA results)
Indeterminate: $17 years 33 (26.2% of indeterminate IGRA results)
Indeterminate: ,17 years 93 (73.8% of indeterminate IGRA results)
Malaria infection (%)
Yes 44 (3.9%)
No 1086 (96.1%)
Schistosoma
serology (%)
Positive 298 (27.7%)
Negative 744 (69.3%)
Equivocal 32 (3.0%)
Strongyloides
serology (%)
Positive 72 (6.4%)
Negative 1023 (90.7%)
Equivocal 33 (2.9%)
Helminth
infection
+ (%)
Yes 444 (39.3%)
No 686 (60.7%)
Vitamin D level
++(%)
Sufficient 161 (14.2%)
Insufficient 891 (78.9%)
Deficient 78 (6.9%)
Haemoglobin (g/L) 130.5617.6
Iron (mmol/L) 13.965.8
Transferrin (mmol/L) 36.765.7
Transferrin saturation (%) 19.769.0
Ferritin (mg/L) 44 (24–78)
Anaemia (%) 203 (18.0%)
Iron Deficiency (%) 166 (14.7%)
Iron deficiency anaemia (%) 80 (7.1%)
Alkaline phosphatase (m/L) 138.5 (75–284)
Phosphate (mmol/L) 1.4 (1.2–1.7)
Total calcium (mmol/L) 2.460.1
Eosinophil count (610
9/L) 0.460.6
*Estimate values represent mean 6 standard deviation or median (interquartile
range) or frequency (percent) of study population.
**Screening through only the QuantiFERONH-TB Gold or QuantiFERONH-TB
Gold In-tube assays.
+Defined as a positive serology to either Schistosoma or S. stercoralis,o ra n
eosinophil count .0.7610
9/L.
++Defined as deficient (,27.5 nmol/L), insufficient (27.5–78 nmol/L) and
sufficient (.78 nmol/L).
doi:10.1371/journal.pone.0038556.t002
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negative IGRA results, depending on the age at assessment. Not adjusted for other covariates in the multivariate model.
doi:10.1371/journal.pone.0038556.g001
Table 3. Characteristics associated with a positive IGRA result (n=1004).
Variable Univariate odds ratio (95% CI*) P value Multivariate odds ratio (95% CI*)
+ P value
+
Gender 0.189 –
Male 1
Female 0.83 (0.62–1.10)
Age at visit ,0.001 ,0.001
Linear 1.10 (1.08–1.12) 1.10 (1.08–1.12)
Quadratic 1.00 (1.00–1.00) 1.00 (1.00–1.00)
Country of birth 0.287 –
Not Africa 1
Africa 1.35 (0.78–2.35)
Seasonality of visit 0.006 0.022
Summer 1 1
Autumn 0.46 (0.28–0.74) 0.49 (0.29–0.82)
Winter 0.52 (0.34–0.79) 0.52 (0.33–0.83)
Spring 0.64 (0.42–0.98) 0.60 (0.39–0.95)
Vitamin D 0.431 –
Deficient 1
Insufficient 1.28 (0.72–2.28)
Sufficient 1.53 (0.79–2.95)
Body mass index
++ 1.04 (0.92–1.18) 0.531 –
Helminth infection 1.84 (1.39–2.45) ,0.001 –
Malaria infection 1.42 (0.65–3.07) 0.376 –
Iron deficiency 0.92 (0.61–1.40) 0.712 –
Iron deficiency anaemia 0.83 (0.45–1.53) 0.541 –
Eosinophil count (Log(610
9/L) 1.08 (0.95–1.22) 0.249 –
*CI=confidence interval.
+Multivariate odds ratio and p-value reported if significant (P,0.05).
++Age- and gender-adjusted variable.
doi:10.1371/journal.pone.0038556.t003
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38556Figure 2. The probability of an indeterminate IGRA based on age. This figure shows the estimated proportion of indeterminate IGRA results
depending on the age at the MHU visit. Not adjusted for other covariates in the multivariate model.
doi:10.1371/journal.pone.0038556.g002
Table 4. Characteristics associated with an indeterminate IGRA result (n=1130).
Variable Univariate odds ratio (95% CI*) P value Multivariate odds ratio (95% CI*)
+ P value
+
Gender 0.932 –
Male 1
Female 0.98 (0.68–1.42)
Age at visit ,0.001 ,0.001
Linear 0.94 (0.93–0.96) 0.93 (0.91–0.95)
Quadratic 1.00 (1.00–1.00) 1.00 (1.00–1.00)
Country of birth 0.746 –
Not Africa 1
Africa 1.12 (0.55–2.30)
Seasonality of visit 0.125 –
Summer 1
Autumn 1.60 (0.86–2.99)
Winter 0.93 (0.49–1.73)
Spring 1.00 (0.54–1.85)
Vitamin D 0.182 –
Deficient 1
Insufficient 2.50 (0.89–6.97)
Sufficient 2.04 (0.66–6.32)
Body mass index
++ 0.97 (0.82–1.14) 0.701 –
Helminth infection 1.42 (0.98–2.05) 0.067 2.26 (1.48–3.46) ,0.001
Malaria infection 4.06 (2.09–7.88) ,0.001 3.04 (1.51–6.09) 0.002
Iron deficiency 1.99 (1.27–3.12) 0.003 –
Iron deficiency anaemia 2.74 (1.58–4.77) ,0.001 2.69 (1.51–4.80) 0.001
Eosinophil (Log(610
9/L) 1.16 (0.99–1.37) 0.066 –
*CI=confidence interval.
+Multivariate odds ratio and p value reported if significant (P,0.05).
++Age- and gender-adjusted variable.
doi:10.1371/journal.pone.0038556.t004
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tion of other ethnic groups to draw firm conclusions about the
generalisability of these data. Although the IGRA used changed
from QFT to QFT-IT during the study period, this did not alter
the findings (data not shown). A further limitation is the lack of
concurrent TST data to ascertain if the co-morbidities affected
the performance of TST in an analogous way. As the diagnosis
of co-morbidities was determined by clinical guidelines that
aimed to identify important infections in a cost-effective way, we
cannot comment on the possible effects of other potentially
prevalent infections. Approximately 80% of the refugee intake
into Australia has received empiric anti-helminth treatment prior
to departure and routine stool microscopy is not performed in
Western Australia. We are therefore unable to comment on the
possible modifying effects of anti-helminth treatment, nor on the
differential effects of other helminths, which may also have
significant immunomodulatory properties. [43] Prospective stud-
ies, including those in other ethnic groups that repeat the IGRA
following treatment of these co-morbidities and those that
investigate ex-vivo cellular immune function are warranted. These
data would address whether the observed associations are causal
and identify underlying mechanisms.
In conclusion the current findings indicate that indeterminate
IGRA results occurred in a substantial proportion of African
paediatric and adult refugees, potentially limiting the utility of this
investigation as a screening tool for TB infection. Co-morbidities
including chronic infections and nutritional deficiencies are
independently associated with an increased risk of an indetermi-
nate IGRA result.
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